CME Group (NASDAQ: CME) has recently received a number of price target changes and ratings updates:
- 7/9/2026 – CME Group had its price target lowered by Barclays PLC from $316.00 to $270.00. They now have an “equal weight” rating on the stock.
- 7/6/2026 – CME Group had its price target lowered by UBS Group AG from $310.00 to $260.00. They now have a “buy” rating on the stock.
- 7/6/2026 – CME Group had its price target lowered by UBS Group AG from $310.00 to $260.00. They now have a “neutral” rating on the stock.
- 7/2/2026 – CME Group had its “outperform” rating reaffirmed by Raymond James Financial, Inc.. They now have a $320.00 price target on the stock.
- 6/30/2026 – CME Group had its price target lowered by The Goldman Sachs Group, Inc. from $267.00 to $245.00. They now have a “sell” rating on the stock.
- 6/25/2026 – CME Group was downgraded by Weiss Ratings from “buy (b+)” to “buy (b)”.
- 6/22/2026 – CME Group had its price target lowered by TD Cowen from $323.00 to $273.00. They now have a “buy” rating on the stock.
- 6/18/2026 – CME Group was upgraded by Keefe, Bruyette & Woods from “market perform” to “outperform”. They now have a $305.00 price target on the stock.
- 6/17/2026 – CME Group was given a new $320.00 price target by Piper Sandler.
- 6/15/2026 – CME Group had its “overweight” rating reaffirmed by Piper Sandler. They now have a $329.00 price target on the stock.
- 6/15/2026 – CME Group had its “overweight” rating reaffirmed by UBS Group AG.
- 6/13/2026 – CME Group was upgraded by Wall Street Zen from “sell” to “hold”.
- 6/11/2026 – CME Group was downgraded by Weiss Ratings from “buy (a-)” to “buy (b+)”.
- 6/11/2026 – CME Group was upgraded by Rothschild & Co Redburn from “neutral” to “buy”. They now have a $323.00 price target on the stock, up from $316.00.
- 6/5/2026 – CME Group was downgraded by Erste Group Bank AG from “buy” to “hold”.
- 5/29/2026 – CME Group had its “buy (a-)” rating reaffirmed by Weiss Ratings.
CME Group Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were given a $1.30 dividend. The ex-dividend date of this dividend was Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 2.2%. CME Group’s dividend payout ratio is presently 44.37%.
Insider Transactions at CME Group
In related news, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the transaction, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. The trade was a 38.62% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director William R. Shepard purchased 325 shares of the firm’s stock in a transaction on Thursday, June 25th. The stock was bought at an average price of $230.57 per share, with a total value of $74,935.25. Following the acquisition, the director owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Company insiders own 0.30% of the company’s stock.
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Articles
- Five stocks we like better than CME Group
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.
